[go: up one dir, main page]

WO2007031291A2 - Foodstuff additive - Google Patents

Foodstuff additive Download PDF

Info

Publication number
WO2007031291A2
WO2007031291A2 PCT/EP2006/008911 EP2006008911W WO2007031291A2 WO 2007031291 A2 WO2007031291 A2 WO 2007031291A2 EP 2006008911 W EP2006008911 W EP 2006008911W WO 2007031291 A2 WO2007031291 A2 WO 2007031291A2
Authority
WO
WIPO (PCT)
Prior art keywords
amino acids
protein
foodstuff additive
additional food
lycopene
Prior art date
Application number
PCT/EP2006/008911
Other languages
German (de)
French (fr)
Other versions
WO2007031291A3 (en
Inventor
Mark Warnecke
Original Assignee
Mark Warnecke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mark Warnecke filed Critical Mark Warnecke
Publication of WO2007031291A2 publication Critical patent/WO2007031291A2/en
Publication of WO2007031291A3 publication Critical patent/WO2007031291A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L17/00Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
    • A23L17/60Edible seaweed
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/18Iodine; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/42Phosphorus; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • the invention relates to a supplementary foodstuff, in particular for use in diets for sustainable obesity therapy.
  • the body responds to dietary deficiencies in energy first by breaking down muscle tissue. Only then will the fat reserves of the body gradually be attacked. Responsible for this is u. a. the negative nitrogen balance. This is different if, at the same time as the diet, a balanced mix of amino acids that is immediately suitable for muscle growth is made available, and at the same time the muscle tissue is promoted through training. In this case, the administration of amino acids for the anabolic muscle tissue. At the same time an intensive fat burning takes place.
  • the invention relates to a supplementary food, in particular for use in diets for sustainable obesity therapy, based on a mixture of amino acids, supplemented by
  • the mass given in connection with the lycopene refers to the tomato extract in the whole, which contains lycopene.
  • 20 - 25 preferably about 22 kg tomatoes are needed.
  • the tomato extract is preferably in powder form.
  • 1 kg of tomatoes contains about 20 mg of lycopene, whereas the content of lycopene in mature tomatoes can be significantly higher at 39-56 mg per 1 kg of tomatoes.
  • More lycopene contain canned tomatoes: about 100 mg per 1 kg of tomatoes.
  • the total amount of lycopene is therefore preferably between 0.05 mg and 0.2 mg, in particular 0.066 mg and 0.11 mg.
  • Lycopene limits the oxidative damage caused by the increased metabolism.
  • Lycopene is a radical scavenger that can neutralize radicals in the human body and thus significantly reduce the likelihood of certain cancers, such as prostate and lung cancer. Such free radicals are increasingly produced in a diet.
  • lycopene is one of the most potent natural quenchers for singlet oxygen that can oxidize amino acids in proteins, nucleic acids and unsaturated fatty acids. Lycopene is a carotenoid found in tomatoes, rose hips, grapefruit, chanterelles and guavas and is rapidly absorbed by the intestine.
  • the KeIp is derived from brown algae and is rich in calcium, iodine, iron, alkali and minerals. Particularly preferred is the use of Ascophyllum nodosum as brown algae from the Fucales family. Ascophyllum nodosum contains iodine u. a. a larger amount of alginates capable of binding toxic heavy metal ions in the gut and digesting them.
  • the KeIp is preferably used as a fine powder with a grain size of about 250 microns.
  • a typical composition in% of the dry matter is:
  • iodine plays a major role in the production of thyroid hormones. It has been found that the high iodine content in the KeIp helps reduce unwanted fat. The high content of iron, which is indispensable for the oxygenation of the tissue, strengthens the organism.
  • the additional food according to the invention is also well suited for the correction of malnutrition.
  • Magnesium deficiency can trigger cardiac arrhythmia and convulsions in humans. Especially with low carbohydrate diet and diets and athletes there is an increased risk of magnesium deficiency.
  • Phosphates are essential for all living things.
  • phosphate radicals constitute constituents of DNA and RNA molecules.
  • Phosphorus compounds (ATP, ADP, etc.) also play a special role in metabolism.
  • Calcium phosphates are among the main components of the skeletal substances of bones and teeth.
  • Magnesium and potassium may, for. B. be used in the form of magnesium oxide and potassium bicarbonate.
  • the amino acid mixture used for the supplementary food according to the invention preferably contains
  • amino acids used according to the invention are largely split oligopeptides. Ideally, all amino acids are monomeric. For the purposes of the invention, however, it has been found to be sufficient if the peptide bonds are largely split, d. H. Some amino acids may still be present as short-chain oligopeptides. Under short-chain oligopeptides peptides with max. 20, preferably 10 amino acids, more preferably 5 amino acids understood.
  • This amino acid mixture is optimized in terms of nutritional physiology insofar as it immediately contains all essential building blocks required for the development of endogenous protein in the right proportions.
  • arginine and lysine are considered growth hormone stimulants that promote fat mobilization and fat burning.
  • Phenylalanine stimulates the production of the hormone cholecystokinin, which controls hunger and appetite.
  • Another advantage of such an amino acid mixture is that it provides in conjunction with the added mineral salts, the iodine and the trace elements contained in KeIp for a balanced nitrogen balance.
  • Glycine also has an appetizing effect.
  • Leucine stimulates protein synthesis (muscle growth) and keeps blood sugar levels stable.
  • Arginine has been shown to be effective against arteriosclerosis (vascular calcification).
  • Methionine is involved in the production of noradrenaline and camitine, which is responsible for the transport of fatty acids through the mitochondrial membrane, where the oxidative degradation of fatty acids occurs.
  • Proline is u. a. a starting material for polyamines, which are essential for cell growth and cell differentiation and develop anabolic action.
  • the additional foodstuff consists for example of an amino acid mixture consisting of L-alanine 8.7 g
  • the dietary supplement is fat free, carbohydrate free, purine free and cholesterol free. It is taken as part of a formula diet as a substitute or as a supplement to meals. The dosage is ever according to body weight of the patient between 40 g per day and 80 g per day. The therapy should be accompanied by qualified dieticians and / or medically.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to a foodstuff additive in particular for diets for a lasting adiposity therapy. The aim of said invention is to deliver a foodstuff additive for a lasting adiposity therapy for facilitating muscle-building and simultaneously fat-burning without excessive body training. For this purpose, the inventive foodstuff additive is based on a balanced aminoacid mixture whose quantitative ratio is nutritionally and physiologically optimal and which is supplemented with mineral salts containing 0.5-0.7g of calcium phosphate, 0.3-0.4 g of magnesium, 0.15-0.25 g of potassium, 0.04-0.06 of kelp which contains 7-8 mg iodine and oligoelements and from 0.15 to 0.25 g of lycopin-containing tomato extract. The totality of said indications is given in relation to 100 g of protein.

Description

Zusatznahrunαsmittel Zusatznahrunαsmittel

Die Erfindung betrifft ein Zusatznahrungsmittel, insbesondere für die Verwendung bei Diäten zur nachhaltigen Adipositastherapie.The invention relates to a supplementary foodstuff, in particular for use in diets for sustainable obesity therapy.

Aus der Sportmedizin ist es bekannt, dass die Einnahme von Aminosäuren in Kombination mit einer kalorienreduzierenden Ernährungsweise und Sport zur Gewichtsreduzierung führen, und zwar ohne den Abbau von Muskelgewebe, wenn zugleich intensiv trainiert wird.It is known from sports medicine that the intake of amino acids in combination with a calorie-reducing diet and exercise lead to weight reduction, without the reduction of muscle tissue, if at the same time intensively trained.

Normalerweise reagiert der Körper auf durch Diäten bewirkten Energiemangel zunächst mit Abbau von Muskelgewebe. Erst danach werden nach und nach auch die Fettreserven des Körpers in Angriff genommen. Verantwortlich hierfür ist u. a. die negative Stickstoffbilanz. Das ist anders, wenn zugleich mit der Diät eine ausgewogene und sofort für den Muskelaufbau geeignete Mischung an Aminosäuren zur Verfügung gestellt wird und gleichzeitig das Muskelgewebe durch Training gefördert wird. In diesem Fall wirkt die Gabe an Aminosäuren für das Muskelgewebe anabol. Zugleich findet eine intensive Fettverbrennung statt.Normally, the body responds to dietary deficiencies in energy first by breaking down muscle tissue. Only then will the fat reserves of the body gradually be attacked. Responsible for this is u. a. the negative nitrogen balance. This is different if, at the same time as the diet, a balanced mix of amino acids that is immediately suitable for muscle growth is made available, and at the same time the muscle tissue is promoted through training. In this case, the administration of amino acids for the anabolic muscle tissue. At the same time an intensive fat burning takes place.

Dieser wünschenswerte Effekt wird allerdings erheblich reduziert, wenn das be- gleitende Training weniger intensiv ist.However, this desirable effect is significantly reduced if the accompanying training is less intense.

Es ist deshalb Aufgabe der Erfindung, ein für die nachhaltige Adipositastherapie geeignetes, Diät begleitendes Zusatznahrungsmittel bereit zu stellen, welches den Muskelaufbau bei gleichzeitiger Fettverbrennung fördert, ohne auf übermäßiges körperliches Training angewiesen zu sein. Gegenstand der Erfindung ist ein Zusatznahrungsmittel, insbesondere für die Verwendung bei Diäten zur nachhaltigen Adipositastherapie, auf der Basis einer Mischung von Aminosäuren, ergänzt durchIt is therefore an object of the invention to provide a suitable for sustainable obesity therapy, diet accompanying supplementary food, which promotes muscle growth with simultaneous fat burning, without having to rely on excessive exercise. The invention relates to a supplementary food, in particular for use in diets for sustainable obesity therapy, based on a mixture of amino acids, supplemented by

Mineralsalze, enthaltend 0,5 g bis 0,7 g Calciumphosphat, 0,3 g bis 0,4 g Magnesium und 0,15 g bis 0,25 g Kalium,Mineral salts containing 0.5 g to 0.7 g of calcium phosphate, 0.3 g to 0.4 g of magnesium and 0.15 g to 0.25 g of potassium,

0,04 g bis 0,06 g KeIp, enthaltend 7 mg bis 8 mg Jod und Spurenelemente, und0.04 g to 0.06 g KeIp containing 7 mg to 8 mg iodine and trace elements, and

0,15 g bis 0,25 g Lycopin in Form von Tomatenextrakt.0.15 g to 0.25 g lycopene in the form of tomato extract.

(Sämtliche Gewichtsangaben bezogen auf 100 g Protein).(All weights are based on 100 g of protein).

Die im Zusammenhang mit dem Lycopin angegebene Masse bezieht sich auf den Tomatenextrakt im Ganzen, der lycopinhaltig ist. Um 1 kg Tomatenextrakt zu erhalten, werden 20 - 25, vorzugsweise ca. 22 kg Tomaten benötigt. Der Tomatenextrakt liegt vorzugsweise pulverförmig vor. 1 kg Tomaten enthält ca. 20 mg Lycopin, wobei der Gehalt an Lycopin bei reifen Tomaten deutlich höher bei 39 - 56 mg pro 1 kg Tomaten liegen kann. Noch mehr Lycopin enthalten Dosentomaten: ca. 100 mg pro 1 kg Tomaten. Die Gesamtmenge an Lycopin beträgt demnach vorzugsweise zwischen 0,05 mg und 0,2 mg, insbesondere 0,066 mg und 0,11 mg.The mass given in connection with the lycopene refers to the tomato extract in the whole, which contains lycopene. To obtain 1 kg of tomato extract, 20 - 25, preferably about 22 kg tomatoes are needed. The tomato extract is preferably in powder form. 1 kg of tomatoes contains about 20 mg of lycopene, whereas the content of lycopene in mature tomatoes can be significantly higher at 39-56 mg per 1 kg of tomatoes. More lycopene contain canned tomatoes: about 100 mg per 1 kg of tomatoes. The total amount of lycopene is therefore preferably between 0.05 mg and 0.2 mg, in particular 0.066 mg and 0.11 mg.

Grundsätzlich ist es selbstverständlich auch möglich, Lycopin in entsprechender Menge zuzusetzen, das aus anderen Quellen gewonnen wurde.In principle, it is of course also possible to add lycopene in an appropriate amount, which was obtained from other sources.

Es hat sich überraschenderweise herausgestellt, dass durch die Zugabe der angegebenen Mineralsalze und der im KeIp enthaltenen Substanzen (Jod und Spurenelemente) in Verbindung mit einer ausgewogenen, ernähungs- physiologisch optimierten Aminosäuremischung der Stoffwechsel des Körpers außerordentlich intensiv angeregt wird, wodurch die sonst nur durch körperliches Training bewirkte Anregung zum Muskelaufbau zu einem großen Teil substituiert wird. Es kommt also auch ohne intensives Training zum Aufbau von Muskelgewebe und zum Abbau von Fettgewebe. Völlig ersetzen lässt sich allerdings das Training nicht. Es kann aber auf ein für den jeweiligen Patienten angemessenes Maß reduziert werden.It has surprisingly been found that by adding the indicated mineral salts and the substances contained in KeIp (iodine and trace elements) in conjunction with a balanced, nutritionally physiologically optimized amino acid mixture, the metabolism of the body is stimulated extremely intense, which otherwise only by physical Training induced stimulation to build muscle is substituted to a large extent. It comes so even without intensive training to build of muscle tissue and breakdown of adipose tissue. However, the training can not be completely replaced. However, it can be reduced to an appropriate level for the respective patient.

Durch die Zugabe des Antioxidativmittels Lycopin werden die von dem verstärkten Stoffwechsel ausgehenden oxidativen Schäden begrenzt. Lycopin ist ein Radikalfänger, der Radikale im menschlichen Körper unschädlich machen und auf diese Weise die Wahrscheinlichkeit für bestimmte Krebsarten, beispielsweise Prostata- und Lungenkrebs, signifikant reduzieren kann. Derartige freie Radikale entstehen bei einer Diät vermehrt. Insbesondere gehört Lycopin zu den wirksamsten natürlichen Quenchern für Singulettsauerstoff, der Aminosäuren in Proteinen, Nukleinsäuren und ungesättigte Fettsäuren oxidieren kann. Lycopin ist ein Carotinoid, das insbesondere in Tomaten, Hagebutten, Grapefruits, Pfifferlingen und Guaven vorkommt und vom Darm schnell resorbiert wird.The addition of the antioxidant lycopene limits the oxidative damage caused by the increased metabolism. Lycopene is a radical scavenger that can neutralize radicals in the human body and thus significantly reduce the likelihood of certain cancers, such as prostate and lung cancer. Such free radicals are increasingly produced in a diet. In particular, lycopene is one of the most potent natural quenchers for singlet oxygen that can oxidize amino acids in proteins, nucleic acids and unsaturated fatty acids. Lycopene is a carotenoid found in tomatoes, rose hips, grapefruit, chanterelles and guavas and is rapidly absorbed by the intestine.

Der KeIp wird aus Braunalgen gewonnen und ist reich an Calcium, Jod, Eisen, Alkali und Mineralien. Besonders bevorzugt ist die Verwendung von Ascophyllum nodosum als Braunalge aus der Fucales-Familie. Ascophyllum nodosum enthält neben Jod u. a. eine größere Menge Alginate, die in der Lage sind, giftige Schwermetallionen im Darminhalt zu binden und für deren Ausscheidung mit der Verdauung zu sorgen. Der KeIp wird bevorzugt als feines Pulver mit einer Körnung von ca. 250 μm eingesetzt. Eine typische Zusammensetzung in % der Trockenmasse ist:The KeIp is derived from brown algae and is rich in calcium, iodine, iron, alkali and minerals. Particularly preferred is the use of Ascophyllum nodosum as brown algae from the Fucales family. Ascophyllum nodosum contains iodine u. a. a larger amount of alginates capable of binding toxic heavy metal ions in the gut and digesting them. The KeIp is preferably used as a fine powder with a grain size of about 250 microns. A typical composition in% of the dry matter is:

Figure imgf000004_0001
Figure imgf000004_0001

Jod spielt im Organismus hauptsächlich eine Rolle für die Produktion von Schilddrüsenhormonen. Es hat sich herausgestellt, dass der hohe Jodgehalt im KeIp beim Abbau von unerwünschtem Fett hilft. Der hohe Gehalt an Eisen, das für die Sauerstoffversorgung des Gewebes unabdingbar ist, stärkt den Organismus.In the organism, iodine plays a major role in the production of thyroid hormones. It has been found that the high iodine content in the KeIp helps reduce unwanted fat. The high content of iron, which is indispensable for the oxygenation of the tissue, strengthens the organism.

Das erfindungsgemäße Zusatznahrungsmittel ist auch gut zur Korrektur von Fehlernährungen geeignet. Magnesiummangel kann beim Menschen Herzrhythmusstörungen und Krämpfe auslösen. Gerade bei kohlenhydratarmer Ernährung und Diäten sowie bei Sportlern besteht eine erhöhte Gefahr von Magnesiummangel.The additional food according to the invention is also well suited for the correction of malnutrition. Magnesium deficiency can trigger cardiac arrhythmia and convulsions in humans. Especially with low carbohydrate diet and diets and athletes there is an increased risk of magnesium deficiency.

Phosphate sind für sämtliche Lebewesen essentiell. Insbesondere stellen Phosphatreste Bestandteile der DNA- und RNA-Moleküle dar. Auch im Stoffwechsel spielen Phosphorverbindungen (ATP, ADP, etc.) eine besondere Rolle. Calciumphosphate gehören zu den Hauptbestandteilen der Gerüstsubstanzen von Knochen und Zähnen.Phosphates are essential for all living things. In particular, phosphate radicals constitute constituents of DNA and RNA molecules. Phosphorus compounds (ATP, ADP, etc.) also play a special role in metabolism. Calcium phosphates are among the main components of the skeletal substances of bones and teeth.

Magnesium und Kalium können z. B. in Form von Magnesiumoxid und Kaliumhydrogencarbonat eingesetzt werden.Magnesium and potassium may, for. B. be used in the form of magnesium oxide and potassium bicarbonate.

Das für das Zusatznahrungsmittel gemäß der Erfindung verwendete Aminosäurengemisch enthält vorzugsweiseThe amino acid mixture used for the supplementary food according to the invention preferably contains

L-Alanin 8,7 g +/- 10 %L-Alanine 8.7 g +/- 10%

L-Arginin 8,15 g +/- 10 % L-Asparaginsäure 6 g +/- 10 %L-arginine 8,15 g +/- 10% L-aspartic acid 6 g +/- 10%

L-Glutaminsäure 11 ,1 g +/- 10 %L-glutamic acid 11, 1 g +/- 10%

L-Glycin 20,6 g +/- 10 %L-Glycine 20.6 g +/- 10%

L-Histidin 0,6 g +/- 10 %L-histidine 0.6 g +/- 10%

L-Hydroxylysin 1 g +/- 10 % L-Hydroxyprolin 11 ,4 g +/- 10 % L-Isoleucin 1 ,6 g +/- 10 %L-hydroxylysine 1 g +/- 10% L-hydroxyproline 11, 4 g +/- 10% L-isoleucine 1, 6 g +/- 10%

L-Leucin 3,3 g +/- 10 %L-leucine 3.3 g +/- 10%

L-Lysin 3,9 g +/- 10 %L-lysine 3.9 g +/- 10%

L-Methionin 0,6 g +/- 10 % L-Phenylalanin 2,1 g +/- 10 %L-methionine 0.6 g +/- 10% L-phenylalanine 2.1 g +/- 10%

L-Prolin 13,3 g +/- 10 %L-proline 13.3 g +/- 10%

L-Serin 3,1 g +/- 10 %L-serine 3.1 g +/- 10%

L-Threonin 1 ,8 g +/- 10 %L-threonine 1, 8 g +/- 10%

L-Tyrosin 0,35 g +/- 10 % L-VaNn 2,4 g +/- 10 %L-Tyrosine 0,35 g +/- 10% L-VaNn 2,4 g +/- 10%

(Alle Gewichtsangaben bezogen auf 100 g Protein).(All weights based on 100 g of protein).

Bei den erfindungsgemäß verwendeten Aminosäuren handelt es sich um weitgehend aufgespaltene Oligopeptide. Idealerweise liegen sämtliche Aminosäuren monomer vor. Für die Zwecke der Erfindung hat es sich jedoch als ausreichend herausgestellt, wenn die Peptidbindungen weitgehend aufgespalten sind, d. h. einige Aminosäuren können noch als kurzkettige Oligopeptide vorliegen. Dabei werden unter kurzkettigen Oligopeptiden Peptide mit max. 20, vorzugsweise 10 Aminosäuren, besonders bevorzugt 5 Aminosäuren verstanden.The amino acids used according to the invention are largely split oligopeptides. Ideally, all amino acids are monomeric. For the purposes of the invention, however, it has been found to be sufficient if the peptide bonds are largely split, d. H. Some amino acids may still be present as short-chain oligopeptides. Under short-chain oligopeptides peptides with max. 20, preferably 10 amino acids, more preferably 5 amino acids understood.

Die Verwendung von einzelnen Aminosäuren anstelle langkettiger Proteine hat den Vorteil, dass der Körper die Aminosäuren unmittelbar aufnehmen kann, ohne die Peptidbindungen der Proteine zunächst spalten zu müssen. Die Resorptionsrate wird damit deutlich erhöht. Bei der Verwendung von Proteinen hingegen wird ein erheblicher Teil vom Körper nicht aufgenommen und letztlich wieder ausgeschieden. Die Verabreichung von monomeren Aminosäuren oder sehr kurzkettigen Oligopeptiden ist daher erheblich effizienter. Die Gewichtsangabe „bezogen auf 100 g Protein" ist dabei so zu verstehen, dass als Protein die Gesamtmenge an Aminosäuren anzusehen ist.The use of individual amino acids instead of long-chain proteins has the advantage that the body can absorb the amino acids directly without first having to cleave the peptide bonds of the proteins. The absorption rate is thus significantly increased. When using proteins, however, a significant part of the body is not absorbed and ultimately excreted. The administration of monomeric amino acids or very short chain oligopeptides is therefore considerably more efficient. The Weight indication "based on 100 g protein" is to be understood that the total amount of amino acids is to be regarded as protein.

Diese Aminosäuremischung ist insofern ernährungsphysiologisch optimiert, als sie sofort alle wesentlichen, für den Aufbau von körpereigenem Eiweiß erforderlichen Bausteine im richtigen Mengenverhältnis bereithält. Außerdem gelten Arginin und Lysin als Stimulanzien des Wachstumshormons, welches die Fettmobilisierung und die Fettverbrennung fördert. Phenylalanin stimuliert die Produktion des Hormons Cholecystokinin, welches den Hunger und Appetit steuert. Ein weiterer Vorteil einer solchen Aminosäuremischung besteht darin, dass sie im Zusammenwirken mit den zugesetzten Mineralsalzen, dem Jod und den im KeIp enthaltenen Spurenelementen für eine ausgeglichene Stickstoffbilanz sorgt.This amino acid mixture is optimized in terms of nutritional physiology insofar as it immediately contains all essential building blocks required for the development of endogenous protein in the right proportions. In addition, arginine and lysine are considered growth hormone stimulants that promote fat mobilization and fat burning. Phenylalanine stimulates the production of the hormone cholecystokinin, which controls hunger and appetite. Another advantage of such an amino acid mixture is that it provides in conjunction with the added mineral salts, the iodine and the trace elements contained in KeIp for a balanced nitrogen balance.

Auch die weiteren verwendeten Aminosäuren üben vorteilhafte Wirkungen aus. So wirkt auch Glycin appetitzügelnd. Leucin stimuliert die Eiweissynthese (Muskelaufbau) und hält den Blutzuckerspiegel stabil. Arginin hat sich als wirkungsvoll gegen Arteriosklerose (Gefäßverkalkung) herausgestellt. Methionin ist an der Bildung von Noradrenalin und Camitin beteiligt, welches für den Transport der Fettsäuren durch die Mitochondrienmembran verantwortlich ist, wo der oxidative Abbau der Fettsäuren erfolgt. Prolin ist u. a. ein Ausgangsstoff für Polyamine, die für Zellwachstum und Zelldifferenzierung essentiell sind und anabole Wirkung entfalten.The other amino acids used also exert beneficial effects. Glycine also has an appetizing effect. Leucine stimulates protein synthesis (muscle growth) and keeps blood sugar levels stable. Arginine has been shown to be effective against arteriosclerosis (vascular calcification). Methionine is involved in the production of noradrenaline and camitine, which is responsible for the transport of fatty acids through the mitochondrial membrane, where the oxidative degradation of fatty acids occurs. Proline is u. a. a starting material for polyamines, which are essential for cell growth and cell differentiation and develop anabolic action.

Konkretes Ausführungsbeispiel:Specific embodiment:

Das Zusatznahrungsmittel besteht beispielsweise aus einer Aminosäuremischung bestehend aus L-Alanin 8,7 gThe additional foodstuff consists for example of an amino acid mixture consisting of L-alanine 8.7 g

L-Arginin 8,15 gL-arginine 8.15 g

L-Asparaginsäure 6 g L-Glutaminsäure 11,1 g L-Glycin 20,6 g L-Histidin 0,6 gL-aspartic acid 6 g L-glutamic acid 11.1 g L-Glycine 20.6 g L-histidine 0.6 g

L-Hydroxylysin 1 gL-hydroxylysine 1 g

L-Hydroxyprolin 11 ,4 g L-Isoleucin 1 ,6 gL-hydroxyproline 11, 4 g of L-isoleucine 1, 6 g

L-Leucin 3,3 gL-leucine 3.3 g

L-Lysin 3,9 gL-lysine 3.9 g

L-Methionin 0,6 gL-methionine 0.6 g

L-Phenylalanin 2,1 g L-Prolin 13,3 gL-phenylalanine 2.1 g L-proline 13.3 g

L-Serin 3,1 gL-serine 3.1 g

L-Threonin 1 ,8 gL-threonine 1, 8 g

L-Tyrosin 0,35 gL-tyrosine 0.35 g

L-Valin 2,4 g Weiterhin enthält das ZusatznahrungsmittelL-valine 2.4 g Further contains the additional food

Calciumphosphat 0,63 gCalcium phosphate 0.63 g

Magnesium 0,39 gMagnesium 0.39 g

Kalium 0,18 gPotassium 0.18 g

KeIp 0,05 g davon Jod 7,5 mg + Spuren Tomatenextrakt enthaltend Lycopin 0,18 g.KeIp 0.05 g of which iodine 7.5 mg + traces of tomato extract containing lycopene 0.18 g.

Das Nahrungsergänzungsmittel ist frei von Fett, frei von Kohlenhydraten, frei von Purin und frei von Cholesterin. Es wird im Rahmen einer Formula-Diät als Ersatz oder als Ergänzung von Mahlzeiten eingenommen. Die Dosierung liegt je nach Körpergewicht des Patienten zwischen 40 g pro Tag und 80 g pro Tag. Die Therapie sollte von qualifizierten Diätassistenten und/oder ärztlich begleitet sein.The dietary supplement is fat free, carbohydrate free, purine free and cholesterol free. It is taken as part of a formula diet as a substitute or as a supplement to meals. The dosage is ever according to body weight of the patient between 40 g per day and 80 g per day. The therapy should be accompanied by qualified dieticians and / or medically.

- Patentansprüche - - Claims -

Claims

Patentansprüche claims 1. Zusatznahrungsmittel, insbesondere für die Verwendung bei Diäten zur nachhaltigen Adipositastherapie, auf der Basis einer Mischung von1. Additional food, in particular for use in diets for sustainable obesity therapy, based on a mixture of 5 Aminosäuren, ergänzt durch5 amino acids, supplemented by Mineralsalze, enthaltend 0,5 g bis 0,7 g Calciumphosphat, 0,3 g bis 0,4 g Magnesium und 0,15 g bis 0,25 g Kalium,Mineral salts containing 0.5 g to 0.7 g of calcium phosphate, 0.3 g to 0.4 g of magnesium and 0.15 g to 0.25 g of potassium, 0,04 g bis 0,06 g KeIp, enthaltend 7 mg bis 8 mg Jod und Spurenelemente, und0.04 g to 0.06 g KeIp containing 7 mg to 8 mg iodine and trace elements, and lo - 0,15 g bis 0,25 g Lycopin haltiger Tomatenextrakt;lo - 0.15 g to 0.25 g lycopene-containing tomato extract; sämtliche Gewichtsangaben bezogen auf 100 g Protein.all weights based on 100 g of protein. 2. Zusatznahrungsmittel nach Anspruch 1 , dadurch gekennzeichnet, dass die Aminosäuren als Monomere vorliegen.2. Additional food according to claim 1, characterized in that the amino acids are present as monomers. 3. Zusatznahrungsmittel nach Anspruch 1 oder 2, dadurch i5 gekennzeichnet, dass der KeIp aus Algen der Gattung Ascophyllum nodosum gewonnen ist.3. Additional food according to claim 1 or 2, characterized i5 characterized in that the KeIp is obtained from algae of the genus Ascophyllum nodosum. 4. Zusatznahrungsmittel nach einem der Ansprüche 1 bis 3,4. Additional food according to one of claims 1 to 3, bei welchem die Aminosäuremischung enthält: L-Alanin 8,7 g +/- 10 %in which the amino acid mixture contains: L-Alanine 8.7 g +/- 10% L-Arginin 8,15 g +/- 10 %L-arginine 8.15 g +/- 10% L-Asparaginsäure 6 g +/- 10 %L-aspartic acid 6 g +/- 10% L-Glutaminsäure 11 ,1 g +/- 10 %L-glutamic acid 11, 1 g +/- 10% L-Glycin 20,6 g +/- 10 %L-Glycine 20.6 g +/- 10% L-Histidin 0,6 g +/- 10 %L-histidine 0.6 g +/- 10% L-Hydroxylysin 1 g +/- 10 %L-hydroxylysine 1 g +/- 10% L-Hydroxyprolin 11 ,4 g +/- 10 %L-hydroxyproline 11, 4 g +/- 10% L-Isoleucin 1 ,6 g +/- 10 %L-isoleucine 1, 6 g +/- 10% L-Leucin 3,3 g +/- 10 %L-leucine 3.3 g +/- 10% L-Lysin 3,9 g +/- 10 %L-lysine 3.9 g +/- 10% L-Methionin 0,6 g +/- 10 %L-methionine 0.6 g +/- 10% L-Phenylalanin 2,1 g +/- 10 %L-phenylalanine 2.1 g +/- 10% L-Prolin 13,3 g +/- 10 %L-proline 13.3 g +/- 10% L-Serin 3,1 g +/- 10 %L-serine 3.1 g +/- 10% L-Threonin 1 ,8 g +/- 10 %L-threonine 1, 8 g +/- 10% L-Tyrosin 0,35 g +/- 10 % L-Valin 2,4 g +/-10%L-Tyrosine 0.35 g +/- 10% L-valine 2.4 g +/- 10% (Alle Gewichtsangaben bezogen auf 100 g Protein).(All weights based on 100 g of protein). - Zusammenfassung - - Summary -
PCT/EP2006/008911 2005-09-14 2006-09-13 Foodstuff additive WO2007031291A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005043986.1 2005-09-14
DE102005043986A DE102005043986A1 (en) 2005-09-14 2005-09-14 Additional food

Publications (2)

Publication Number Publication Date
WO2007031291A2 true WO2007031291A2 (en) 2007-03-22
WO2007031291A3 WO2007031291A3 (en) 2007-05-10

Family

ID=37607245

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/008911 WO2007031291A2 (en) 2005-09-14 2006-09-13 Foodstuff additive

Country Status (2)

Country Link
DE (1) DE102005043986A1 (en)
WO (1) WO2007031291A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2009317C2 (en) * 2012-08-13 2014-02-18 Invent 4 You B V Mutant tomatoes and use thereof for preventing weight gain and/or treating obesity-related conditions.
US10183052B2 (en) 2015-02-13 2019-01-22 Green4Health B.V. Mutant tomatoes and use thereof for preventing weight gain and/or treating obesity-related conditions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2268871A (en) * 1992-07-04 1994-01-26 Bio Nutritional Health Service Composition for use as a food or food supplement
US5744161A (en) * 1995-02-24 1998-04-28 Sabinsa Corporation Use of piperine as a bioavailability enhancer
US6224871B1 (en) * 1998-03-11 2001-05-01 Reliv International, Inc. Dietary supplement for nutritionally promoting healthy joint function
GB2353471B (en) * 1999-07-06 2004-08-18 Daniel I Vigdorovich Composition for treating obesity and related disorders and using therof
WO2002012882A2 (en) * 2000-08-08 2002-02-14 Buchanan Baillie Hamilton Paul Slimming system
US7030092B1 (en) * 2001-08-24 2006-04-18 Small Giant L.L.C. Ultra-high fiber supplement and method of reducing weight cardiovascular risks and ingested toxins.
JP2003160505A (en) * 2001-09-12 2003-06-03 Lion Corp Food and drink as well as external preparation with body fat reducing effect
US20040001817A1 (en) * 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
US7445807B2 (en) * 2002-10-15 2008-11-04 Western Holdings, Llc Agglomerated granular protein-rich nutritional supplement
US20060115556A1 (en) * 2004-12-01 2006-06-01 Foulger Sidney W Nutritional supplement drink containing xanthone extracts

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2009317C2 (en) * 2012-08-13 2014-02-18 Invent 4 You B V Mutant tomatoes and use thereof for preventing weight gain and/or treating obesity-related conditions.
WO2014027886A1 (en) * 2012-08-13 2014-02-20 Green4Health B.V. Mutant tomatoes and use thereof for preventing weight gain and/or treating obesity-related conditions
US10183052B2 (en) 2015-02-13 2019-01-22 Green4Health B.V. Mutant tomatoes and use thereof for preventing weight gain and/or treating obesity-related conditions

Also Published As

Publication number Publication date
DE102005043986A1 (en) 2007-04-05
WO2007031291A3 (en) 2007-05-10

Similar Documents

Publication Publication Date Title
US5889040A (en) Composition for increasing protein concentration in a mammal
US8168241B2 (en) Performance-enhancing dietary supplement
US20090098230A1 (en) Nutraceutical moringa composition
KR20020062927A (en) Food supplement for increasing lean mass and strength
WO1994001006A2 (en) Composition for use as a food or food supplement
GB2268871A (en) Composition for use as a food or food supplement
CN108308493A (en) A kind of anti-fatigue solid beverage and preparation method of astaxanthin-containing
Hewlings et al. Sulfur in human health
RU2463811C1 (en) Specialised product for sportspeople alimentation
CN102771690A (en) Muscle building functional food
Rudolf et al. Sport nutrition: the role of macronutrients and minerals in endurance exercises
WO2008100130A2 (en) Composition containing kadok extract and collagen
US20060147600A1 (en) 'Maca Blast' energy drink
RU2376888C2 (en) Dietary supplement
WO2007031291A2 (en) Foodstuff additive
RU2685883C1 (en) Vitaminized drinking water
WO2020210540A2 (en) Nutrient compositions and methods for administering a nutrient composition
Keith Ascorbic acid
RU2492867C1 (en) Biologically active additive
CN109170913A (en) A kind of health composition of peptide containing bird's nest, soybean peptide and bone glue of yak former peptide
RU2105502C1 (en) Biologically active preparation "methiovit"
Dorn et al. A review of antler supplements: Benefits, trends, and potential
EP1214894B1 (en) Food formulations with a high calcium content
EP1228706B1 (en) Composition for enhancing the forming of connective tissue and for conditioning the body for high physical performance
US20180027853A1 (en) Embryonic egg extract composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06792030

Country of ref document: EP

Kind code of ref document: A2